Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis

European Urology

Volumn 58, Issue 3, 2010, Pages 360-365

  Pinto, Rui ^a,b   Lopes, Tiago ^a   Frias, Bárbara ^b   Silva, André ^a,b   Silva, João Alturas ^a,b   Silva, Carlos Martins ^a,b   Cruz, Célia ^b   Cruz, Francisco ^a,b   Dinis, Paulo ^a,b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

BDNF; Bladder pain syndrome; Bladder trigone; Botulinum toxin; Interstitial cystitis; NGF; Pain

Indexed keywords

BOTULINUM TOXIN A; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; PROMETHAZINE; SODIUM CHLORIDE;

ADULT; ARTICLE; BLADDER CAPACITY; BLADDER DISEASE; BLADDER PAIN SYNDROME; CYSTOMETRY; DRUG EFFICACY; DRUG SCREENING; DRUG TOLERABILITY; EXPLORATORY RESEARCH; FEMALE; FOLLOW UP; HUMAN; INTERSTITIAL CYSTITIS; KIDNEY CONCENTRATING CAPACITY; MAJOR CLINICAL STUDY; OBSERVATION; OLEARY SANT SCORE; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN URINE LEVEL; QUALITY OF LIFE; RATING SCALE; RETREATMENT; SEDATION; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; URINARY FREQUENCY; URODYNAMICS;

ADMINISTRATION, INTRAVESICAL; BOTULINUM TOXINS, TYPE A; CYSTITIS, INTERSTITIAL; FEMALE; HUMANS; MIDDLE AGED; NEUROMUSCULAR AGENTS;

EID: 77955512471     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.02.031     Document Type: Article

References (30)

1. P. Abrams, L. Cardozo, and M. Fall The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society Neurourol Urodyn 21 2002 167 178 (Pubitemid 34195211)
2. J.P. Van de Merwe, J. Nordling, and P. Bouchelouche Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal Eur Urol 53 2008 60 67
3. A. Apostolidis, P. Dasgupta, and P. Denys Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report Eur Urol 55 2009 100 120
4. Y.C. Chuang, N. Yoshimura, and C.C. Huang Intravesical botulinum toxin A administration produces analgesia against acetic acid induced bladder pain response in rats J Urol 172 2004 1529 1532
5. D.E. Rapp, K.W. Turk, and G.T. Bales Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder J Urol 175 2006 1138 1142
6. A. Avelino, C. Cruz, and I. Nagy Vanilloid receptor 1 expression in the rat urinary tract Neuroscience 109 2002 787 798
7. A. Giannantoni, M. Porena, and E. Costantini Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-yr follow-up J Urol 179 2008 1031 1034
8. H.C. Kuo, and M.B. Chancellor Comparison of intravesical botulinum toxin type A injections plus hydrodistension with hydrodistension alone for the treatment of refractory interstitial cystitis/painful bladder syndrome BJU Int 1 2009 1 5
9. G. Karsenty, E. Elzayat, and T. Delapparent Botulinum toxin type A injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux J Urol 177 2007 1011 1014
10. H.T. Liu, P. Tyagi, and M.B. Chancellor Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment BJU Int 104 2009 1476 1481
11. J. Nordling, F.H. Anjum, and J.J. Bade Primary evaluation of patients suspected of having interstitial cystitis (IC) Eur Urol 45 2004 662 669
12. M.P. O'Leary, R.S. Grannum, and J.F. Floyd The Interstitial Cystitis Symptom Index and Problem Index Urology 49 1997 58 63
13. P. Dinis, A. Charrua, and A. Avelino Intravesical resiniferatoxin decreases spinal c-fos expression and increases bladder volume to reflex micturition in rats with chronic inflamed urinary bladders BJU Int 94 2004 153 157
14. G. Mukerji, Y. Yiangou, and S.K. Agarwal Transient receptor potential vanilloid receptor subtype 1 in painful bladder syndrome and its correlation with pain J Urol 176 2006 797 801
15. C. Morenilla-Palao, R. Planells-Cases, and N. García-Sanz Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity J Biol Chem 279 2004 25665 25672
16. M. Khera, G.T. Somogyi, and S. Kiss Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury Neurochem Int 45 2004 987 993
17. L.A. Birder, S.R. Barrick, and J.R. Roppolo Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium Am J Physiol Renal Physiol 285 2003 423 429
18. A. Charrua, C. Reguenga, and J.M. Cordeiro Functional transient receptor potential vanilloid 1 is expressed in human urothelial cells J Urol 182 2009 2944 2950
19. D.A. Cockayne, S.G. Hamilton, and Q.M. Zhu Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice Nature 407 2000 1011 1015
20. Y. Sun, S. Keay, and P.G. De Deyne Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis J Urol 166 2001 1951 1956
21. A. Coelho, P. Dinis, and R. Pinto Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder Eur Urol 57 2010 884 890
22. P.J. Dyck, S. Peroutka, and C. Rask Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans Neurology 48 1997 501 505
23. A. Merighi, C. Salio, and A. Ghirri BDNF as a pain modulator Prog Neurobiol 85 2008 297 317
24. M. Koltzenburg, and H.E. Torebjörk Pain and hyperalgesia in acute inflammatory and chronic neuropathic conditions Lancet 345 1995 1111
25. D.B. Clemow, W.D. Steers, and J.B. Tuttle Stretch-activated signaling of nerve growth factor secretion in bladder and vascular smooth muscle cells from hypertensive and hyperactive rats J Cell Physiol 183 2000 289 300
26. R. Pinto, B. Frias, and S. Allen Sequestration of BDNF by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis Neuroscience 166 2010 907 916
27. M. Fall, F. Oberpenning, and R. Peeker Treatment of bladder pain syndrome/interstitial cystitis 2008: can we make evidence-based decisions? Eur Urol 54 2008 65 78
28. A. Shafik Role of the trigone in micturition J Endourol 12 1998 273 277
29. J.W. Warren, V. Brown, and S. Jacobs Urinary tract infection and inflammation at onset of interstitial cystitis/painful bladder syndrome Urology 71 2008 1085 1090
30. G. Del Poppolo, M.T. Filocamo, and V. Li Marzi Neurogenic detrusor overactivity treated with English botulinum toxin A: 8-yr experience of one single centre Eur Urol 53 2008 1013 1020